1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Malignant Ovarian Clear Cell Tumor: new trials by email Literature Review of Malignant Ovarian Clear Cell Tumor trials Research Report on Malignant Ovarian Clear Cell Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer Epacadostat, Pembrolizumab - Malignant Ovarian Clear Cell Tumor, Recurrent Ovarian Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 14 | 2018-12-21 | 2024-07-26 |
Adnexal Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Ovarian Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
epacadostat (1) · pembrolizumab (1)
National Cancer Institute (NCI) (1)
Puerto Rico (1) · United States (1)
Lilian T Gien (1)
U10CA180868 (1)